Dylan Scott: A New Chapter and a Way to Give Back to the Bleeding Disorder Community
Dylan Scott, Territory Manager at InfuCare Rx, shared a post on LinkedIn:
“A New Chapter and A Way to Give Back to the Bleeding Disorder Community.
I’m excited to share that I’m now working with InfuCare Rx!
One of the things I’m most passionate about is helping people in the bleeding disorder community feel more informed and supported when it comes to specialty pharmacy, hemophilia, and navigating care.
As someone who is also a member of the community, I know how many questions can come up — whether you’re a parent or caregiver, a young person getting ready to manage things on your own, or someone who simply wants to better understand hemophilia.
So, in my spare time, I’ll be creating short TikTok videos covering things like:
- Hemophilia A and B basics
- Understanding factor and other hemophilia treatments
- How specialty pharmacies fit into your care
- Questions you may want to ask your specialty pharmacy
- Tips and information for parents and caregivers
- Things to know as you transition to managing your care independently
- Common questions I hear from the community
- And topics YOU want to know more about
My goal isn’t to tell anyone which treatment, doctor, or pharmacy is right for them. It’s to provide information, share experiences, and help people know what questions to ask.
If you have questions about specialty pharmacy or hemophilia that you’d like me to cover, drop them in the comments or send me a message! I’d love to turn your questions into future videos.
Important disclaimer: These videos and posts are created by me in my personal time as a member of the bleeding disorder community. They are for general educational and informational purposes only and do not represent, speak on behalf of, or necessarily reflect the views of InfuCare Rx or its affiliates. Nothing I share is intended to replace advice from your healthcare provider.
Let’s learn, ask questions, and support each other.”
Stay updated with Hemostasis Today.
-
Sep 5, 2026, 19:20Yubrine Moraa Gachemba: BETULA Adds New Evidence for Catheter-Directed Thrombolysis in PE
-
Sep 5, 2026, 19:18John R. Mehall: The Importance of Anticoagulation Management in ECMO
-
Sep 5, 2026, 19:16Thirunavukkarasu Angappan: Why Hemophilia B Still Needs Both Plasma-Derived and Recombinant Factor IX
-
Sep 5, 2026, 19:15Michelle Leona Cecil: Comprehensive Hemophilia Care Doesn’t Begin and End With One Appointment
-
Sep 5, 2026, 19:13Amparo Santamaria: Stem Cells and Hematology – Unlocking a New Frontier in Ovarian Regeneration
-
Sep 5, 2026, 19:10Strengthening the Public Health System for Blood Disorders – Hemophilia Federation of America
-
Sep 5, 2026, 19:08Deidra D. Harris: Supporting Hemophilia of Georgia and the Bleeding Disorders Community
-
Sep 5, 2026, 19:06Katherine Blackwell: Blessed to Have the Opportunity to Speak at the Hemophilia of Indiana Annual Meeting
-
Sep 5, 2026, 19:04Christy V.: What You Need to Know about GI Bleeding and Hemophilia